Kapidin

Lercanidipine Hydrochloride, the active ingredient in Kapidin, is a calcium channel blocker presented as an oral tablet for oral use. It is used to treat hypertension in adult patients. GNH USA supplies Kapidin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kapidin is a calcium channel blocker indicated for the management of high blood pressure. - Hypertension: lowers elevated arterial pressure by causing vasodilation and reducing peripheral vascular resistance. - Essential hypertension: helps achieve target blood pressure levels in patients with primary hypertension. - Secondary hypertension: may be used as part of combination therapy when high blood pressure is due to an identifiable cause.

Lercanidipine Hydrochloride may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of the ankles or lower legs. - Dizziness: especially upon standing. - Tachycardia: increased heart rate. - Nausea: occasional gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Myocardial infarction: rare occurrence of heart attack. - Hepatic dysfunction: abnormal liver enzyme elevations. - Allergic reactions: rash, pruritus, or urticaria. - Angioedema: swelling of face, lips, or throat. - Cardiac arrhythmias: irregular heart rhythms.

Before initiating therapy with Kapidin, several safety considerations should be observed. - Blood pressure monitoring: ensure adequate control and avoid excessive lowering. - Hepatic impairment: use with caution in patients with liver dysfunction. - Elderly patients: start at lower doses and monitor for orthostatic effects. - Concomitant antihypertensives: assess risk of additive hypotension. - Pregnancy and lactation: safety not established; avoid unless clearly needed. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lercanidipine may interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): can increase plasma levels. - Grapefruit juice: may markedly raise drug concentration. - Other potent vasodilators: risk of severe hypotension.

Moderate Interactions (Monitor Closely):\n- CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce effectiveness. - Diuretics: can enhance blood pressure‑lowering effect. - Beta‑blockers: may require dose adjustment to avoid excessive heart rate reduction.